-
Mashup Score: 0Head and Neck Cancer - 1 year(s) ago
Head and Neck Cancer
Source: ASCOCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
Cancer has proven to be a major burden for the Hispanic community, which accounts for nearly 20% of America’s population. In fact, the leading cause of death for Hispanic Americans is cancer; one in three Hispanics will be diagnosed with cancer in their lifetime. Despite being at a higher risk for certain cancer types, Hispanic Americans, as compared to their non-Hispanic White counterparts, are…
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Cancer has proven to be a major burden for the Hispanic community, which accounts for nearly 20% of America’s population. In fact, the leading cause of death for Hispanic Americans is cancer; one in three Hispanics will be diagnosed with cancer in their lifetime. Despite being at a higher risk for certain cancer types, Hispanic Americans, as compared to their non-Hispanic White counterparts, are…
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Cancer has proven to be a major burden for the Hispanic community, which accounts for nearly 20% of America’s population. In fact, the leading cause of death for Hispanic Americans is cancer; one in three Hispanics will be diagnosed with cancer in their lifetime. Despite being at a higher risk for certain cancer types, Hispanic Americans, as compared to their non-Hispanic White counterparts, are…
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
This series is designed to provide AP laboratory managers and their teams with an opportunity to learn and discuss best practices in NSCLC biomarker testing, discover examples of success stories, and seek guidance on real-life challenges they may face. Session 1, 11/18/21: Standardizing Protocols for Optimal Procurement, Fixation, and Tissue/Cytology Specimen Handling for NSCLC Session 2,…
Source: Zoom Video CommunicationsCategories: Latest Headlines, PathologyTweet
-
Mashup Score: 1
This series is designed to provide AP laboratory managers and their teams with an opportunity to learn and discuss best practices in NSCLC biomarker testing, discover examples of success stories, and seek guidance on real-life challenges they may face. Session 1, 11/18/21: Standardizing Protocols for Optimal Procurement, Fixation, and Tissue/Cytology Specimen Handling for NSCLC Session 2,…
Source: Zoom Video CommunicationsCategories: Latest Headlines, PathologyTweet
-
Mashup Score: 2
PHOENIX — Governor Doug Ducey today signed legislation to ensure patients and their doctors have access to innovative testing that can help determine the most effective medical treatment for cancer and other diseases.Before signing the bill at the Dignity Health Cancer Institute at St. Joseph’s Hospital and Medical Center in Phoenix, the governor said Arizona now joins only a handful of other…
Source: Office of the Arizona GovernorCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
This series is designed to provide AP laboratory managers and their teams with an opportunity to learn and discuss best practices in NSCLC biomarker testing, discover examples of success stories, and seek guidance on real-life challenges they may face. Session 1, 11/18/21: Standardizing Protocols for Optimal Procurement, Fixation, and Tissue/Cytology Specimen Handling for NSCLC Session 2,…
Source: Zoom Video CommunicationsCategories: Latest Headlines, PathologyTweet
-
Mashup Score: 3Wendy Levin, MD, MS #Biofidelity #BiomarkerTesting #Tar - 3 year(s) ago
Wendy Levin, MD, MS , Chief Medical Officer at Biofidelity speaks about the New California Law Increases Access to Biomarker Testing for Late-Stage Cancer
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Podcast - Wendy Levin, MD, MS #Biofidelity #BiomarkerTe - 3 year(s) ago
Wendy Levin, MD, MS , Chief Medical Officer at Biofidelity speaks about the New California Law Increases Access to Biomarker Testing for Late-Stage Cancer
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
We’ve issued a new guideline on #immunotherapy and #BiomarkerTesting in recurrent and metastatic head and neck cancer ➡️ https://t.co/ouRXfSAkBi #hncsm #immunoonc https://t.co/ekcV5pq5Ay